ScoreComparison
Why is GlaxoSmithKline Pakistan Ltd. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 15.50
2
The company has declared Positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at PKR 5,208.62 MM
- NET PROFIT(HY) Higher at PKR 5,081.31 MM
- ROCE(HY) Highest at 30.76%
3
With ROE of 26.6, it has a attractive valuation with a 4 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 0%, its profits have risen by 1136.1% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to GlaxoSmithKline Pakistan Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is GlaxoSmithKline Pakistan Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
GlaxoSmithKline Pakistan Ltd.
-100.0%
4.17
49.36%
Pakistan KSE 100 Share
26.26%
2.81
22.77%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.70%
EBIT Growth (5y)
30.01%
EBIT to Interest (avg)
15.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
2.23
Tax Ratio
37.88%
Dividend Payout Ratio
48.72%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.87%
ROE (avg)
16.75%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
4.68
EV to EBIT
9.57
EV to EBITDA
8.78
EV to Capital Employed
5.73
EV to Sales
2.08
PEG Ratio
0.06
Dividend Yield
3.49%
ROCE (Latest)
59.85%
ROE (Latest)
30.99%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at PKR 7,040.31 MM
NET PROFIT(9M)
At PKR 6,232.64 MM has Grown at 74.03%
ROCE(HY)
Highest at 33.42%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -35.26% (YoY
OPERATING PROFIT MARGIN(Q)
Highest at 26.48 %
-2What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.41 times
NET SALES(Q)
Lowest at PKR 14,188.01 MM
Here's what is working for GlaxoSmithKline Pakistan Ltd.
Operating Cash Flow
Highest at PKR 7,040.31 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (PKR MM)
Net Profit
At PKR 6,232.64 MM has Grown at 74.03%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (PKR MM)
Operating Profit Margin
Highest at 26.48 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -35.26% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at PKR 352.77 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (PKR MM)
Here's what is not working for GlaxoSmithKline Pakistan Ltd.
Net Sales
Lowest at PKR 14,188.01 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (PKR MM)
Inventory Turnover Ratio
Lowest at 2.41 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
